Premium Information is available for this item - Upgrade for $1 a day
6505-01-221-8669
And Protease Extended-Release Tablets Lipase Amylase Simethicone
6505012218669 012218669 NDC00021-1420-01420
January 2023
6

Marketplace 6505-01-221-8669
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-221-8669 1+ Documents (More...)
RQST NE Updated Every Day 6505-01-221-8669 RQST Updated Every Day 6505-01-221-8669 RQST NE Related Documents
NATO Update Count 6 NATO Data Quality NSN 6505-01-221-8669 (Generic Image) 1/1 1.
Restrictions 6505-01-221-8669
6505-01-221-8669 is a And Protease Extended-Release Tablets Lipase Amylase Simethicone that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-221-8669
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-221-8669
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-221-8669
- Part Number
- Manufacturer
- Status
- NDC00021-1420-01420
- Manufacturer
- 17635 - Schwarz Pharma, Inc. (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-221-8669
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 4000.000 Usp Units Amylase Active Ingredient And 480.000 Usp Units Lipase Active Ingredient And 6000.000 Usp Units Protease Active Ingredient And 95.000 Milligrams Simethicone Active Ingredient
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Primary Container Type [CQCT]
- Bottle
- Special Features [FEAT]
- Multilayer Active Ingredient Amount:4000.000 Usp Units Amylase First Layer And 480.000 Usp Units Lipase First Layer And 6000.000 Usp Units Protease First Layer And 70.000 Mg Simethicone First Layer And 25.000 Mg Siemthicone Second Layer;Dosage Form Preparation Method:Two-Layer;
- Total Primary Container Quantity [CSCW]
- 12
Management Data 6505-01-221-8669
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Dec 1985
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Tt
- 00000000100TT
- K
NATO Stock Numbers Related to 6505-01-221-8669
Freight Information 6505-01-221-8669
6505-01-221-8669 has freight characteristics.. 6505-01-221-8669 has a variance between NMFC and UFC when transported by rail and the description should be consulted.